Paychex (PAYX): what its latest earnings reveal
2026-07-03 · By Lubin Danilo, founder of Lubin Investment
On June 24, 2026, Paychex reported quarterly results that beat expectations, yet the stock dropped nearly 5% on a softer growth outlook for next year. My criteria do not change the verdict: this remains a high quality business, but it still is not priced at a level that justifies buying today.
Key takeaways
- Paychex reported fiscal Q4 2026 results on June 24, 2026: revenue of 1.605 billion dollars (up 12.5%), adjusted earnings per share of 1.32 dollars (up 11%).
- Full fiscal year revenue reached 6.51 billion dollars (up 17%), boosted by the Paycor acquisition.
- Guidance for fiscal 2027 points to only 5 to 6% revenue growth, which sent the stock down about 5% on the announcement.
- In my scoring, Paychex keeps its quality score of 9 out of 10: this quarter confirms the existing profile rather than changing it.
- The long standing weak spot, growth and how slowly the company collects from clients, is exactly what the cautious guidance confirms.
- At the current price, the stock still does not sit in my buy zone.
What happened on June 24, 2026
Paychex runs on an unusual fiscal calendar: its fiscal year ends May 31, not December 31. On June 24, 2026, the company released its fourth quarter figures (March through May 2026) together with the full fiscal year 2026 results. Before this release, I had already laid out the quality case for Paychex on the Paychex analysis page: a highly profitable company, but one whose growth I judge a bit soft by my own criteria, with a recurring weakness in how fast it collects payment from clients. Here is what this quarter confirms, or does not.
For the quarter, revenue came in at 1.605 billion dollars, up 12.5% year over year. GAAP diluted earnings per share, the raw accounting figure, jumped 43% to 1.17 dollars. The adjusted figure, which strips out one time items such as costs tied to the Paycor acquisition, rose 11% to 1.32 dollars. For the full fiscal year, revenue reached 6.51 billion dollars, up 17%, and adjusted earnings per share came in at 5.51 dollars, up 11%.
Much of that acceleration comes from an acquisition, not from organic growth. Paychex bought Paycor, a payroll and HR competitor focused on mid sized businesses, and folded it into its results for the full year. Strip that effect out and Paychex's underlying growth looks a lot closer to what it has always been: solid, but far from spectacular.
Despite beating Wall Street's expectations, the stock fell about 5% on the day of the announcement. Two reasons stand out. First, sales and administrative expenses came in higher than analysts expected, which trimmed margins a bit. Second, and more important, the guidance for fiscal 2027: Paychex is now targeting revenue growth of only 5 to 6%, compared with 17% for the year that just ended (or 12.5% on a quarterly basis). CFO Bob Schrader told analysts on the earnings call that this guidance assumes a stable job market, a steady economy, and no further interest rate cuts from the Federal Reserve.
There is another headwind, more technical but very real: the interest Paychex earns on client funds. Between the moment a client company sends money for payroll and the moment Paychex forwards it to employees and tax authorities, a few days pass. Paychex invests that money short term in the meantime and earns interest on it, a genuine revenue line, not an accounting footnote. With the Federal Reserve having cut rates, that interest income is expected to shrink to 195 to 205 million dollars in fiscal 2027, down from more this year. One more drag on reported growth, unrelated to how good the underlying business actually is.
What my framework takes from this
On my site, every stock gets a quality score out of 10, built from ten objective financial criteria: profitability, revenue and profit growth, cash generation, share buybacks, debt levels, return on invested capital, among others. That score says nothing about price: it only measures whether the company, as a profit generating machine, is solid. Paychex scores 9 out of 10, one of the best scores in the enterprise software sector. This quarter changes nothing about that score. It confirms, number by number, the profile I already knew.
Start with what is excellent. Free cash flow margin, meaning the share of revenue that actually turns into cash sitting in the bank once every bill and every investment is paid, sits at 30.8% for Paychex. Out of every 100 dollars of revenue, almost 31 end up as net cash: most companies fall well short of that. Cash ROCE (return on capital employed, measured in cash rather than accounting profit, which is harder to dress up) comes in at 56%, a level very few public companies reach. Net margin, the share of revenue that turns into pure profit, is 27%. Three numbers telling the same story: Paychex is an exceptional cash machine.
The real caveat is growth. Over five years, Paychex's revenue has grown roughly 7.7% a year and earnings per share about 9.3% a year. My method looks for a 10% annual threshold to validate this criterion, and Paychex falls just short on both counts. And as the 2027 guidance just showed (5 to 6%, stripped of the Paycor effect), nothing in this quarter's news reverses that trend. It is structural, not a one time blip.
The other weak spot, quieter but concrete, is days sales outstanding, often called DSO: the average number of days Paychex takes to actually get paid after issuing an invoice. For Paychex, that figure sits at 71 days, long for a subscription based service business. The longer that delay stretches, the more the company has to finance the gap between delivering the service and actually collecting the cash. It is not alarming given Paychex's cash position, but combined with sub 10% growth, it explains why the score sits at 9 rather than 10.
| Criterion | Paychex figure | Threshold in my method | Verdict |
|---|---|---|---|
| Free cash flow margin | 30.8% | The higher, the better | Strength |
| Cash ROCE | 56.0% | Very high return on capital sought | Strength |
| Net margin | 27.0% | Solid profitability | Strength |
| Revenue growth (5 years) | 7.7%/year | Threshold sought: above 10%/year | Weakness |
| Earnings per share growth (5 years) | 9.3%/year | Threshold sought: above 10%/year | Weakness |
| Days sales outstanding | 71 days | Shorter is better | Weakness |
| Net debt / free cash flow | 1.78 | Manageable if well under 3-4 | Strength |
| Valuation (current P/FCF) | about 19 times | Suggested buy price under 64.18 dollars/share | Not in buy zone |
What changes, and what does not, for the thesis
The Paycor acquisition is not just another line in the accounts. It serves a specific strategy: pushing Paychex upmarket, toward larger client companies, where competitors like ADP have traditionally been stronger. CEO John Gibson summed up the quarter this way: 'These results reflect solid execution against two of our strategic priorities, the successful integration of Paycor to advance our upmarket expansion and AI innovation.' Paychex also launched WISE this year, its in house artificial intelligence engine built to analyze workforce data for clients. None of that shows up in this quarter's revenue line, but decisions like these are what build or erode a moat, that competitive edge protecting a company from rivals, over five or ten years.
Here is the honest trade-off. Paychex remains one of the most profitable companies I track, with disciplined capital allocation (it returned 2.2 billion dollars to shareholders this fiscal year, between dividends and buybacks). But its organic growth structurally caps below 10% a year, and the 2027 guidance confirms it in black and white. An excellent company that grows slowly is not bad news by itself. It just means you need to pay accordingly, no more, no less.
And that is exactly where the problem sits today. Paychex currently trades around 19 times its free cash flow (the P/FCF ratio, price to free cash flow: the share price divided by the cash generated each year, in other words how many years of cash it takes to recover your purchase at today's price). Under my valuation framework, using conservative assumptions given this sub 10% growth, the price I would allow myself to pay for Paychex sits below 64.18 dollars a share. The current price is well above that. This quarter changed nothing about that picture: the quality is intact, but the price is not cheap enough yet for me to call this a buying opportunity.
My verdict, without emotion
I am not trying to guess whether Paychex will beat or miss next quarter. I look at whether today's asking price matches the company's actual quality, and I let the market come to me. This quarter confirms what I thought before the release: Paychex remains a very high quality company, with one of the best cash machines I follow, but growth that does not, in my view, justify paying today's price. I keep it on my watchlist, not in my portfolio, until the price meets my assumptions. Judging quality and price separately, without mixing the two, is exactly what I wanted to be able to do for any stock in a few seconds. That is why I built my method and my analysis site. You can track Paychex's score and suggested buy price on its analysis page, and see how these ten criteria are calculated on my methodology page.
FAQ
What did Paychex announce on June 24, 2026?
Its fourth quarter and full fiscal year 2026 results (fiscal year ended May 31). Quarterly revenue of 1.605 billion dollars (up 12.5%), adjusted earnings per share of 1.32 dollars (up 11%), and guidance of only 5 to 6% revenue growth for fiscal 2027.
Why did Paychex stock fall when results beat expectations?
Because the market looks forward, not backward. The 2027 growth guidance (5 to 6%) marks a sharp slowdown from the 17% posted in the year that just ended, much of it inflated by the Paycor acquisition. Higher than expected expenses also weighed on margins. The stock fell about 5% that day.
Does this quarter change Paychex's quality score on Lubin Investment?
No. The score stays at 9 out of 10. The strengths (30.8% cash flow margin, 56% Cash ROCE) and the weaknesses (sub 10% annual growth, 71 day collection period) identified before the results are confirmed by this quarter, not overturned.
Is Paychex stock a buying opportunity after this 5% drop?
Not by my method. Even after the pullback, Paychex trades around 19 times its free cash flow, well above the buy price I would allow myself (under 64.18 dollars a share under my assumptions). A good company is still a bad deal if bought too expensively. This is not personalized investment advice, do your own research.
What is days sales outstanding, and why is it a weakness for Paychex?
It is the average number of days a company takes to actually collect money owed after billing a client. For Paychex, that figure is 71 days, long for this type of business. The higher this figure, the more cash the company ties up while waiting to get paid, which weighs a bit on overall efficiency.
Voir l'analyse PAYX sur Lubin Investment
About the author
Written by Lubin Danilo, founder of Lubin Investment. A self-taught individual investor, I find fundamental analysis fascinating, and it has delivered excellent results. For three years now, my performance has beaten the S&P 500. But analyzing every stock took too much time: sites with incomplete data, calculation methods and criteria never aligned with mine. And spotting the best stocks was just as time-consuming, even with my own well-defined checklist. So I put my software development background to work to build this software, base my investment strategy on its results, and share it with people who share the same passion as me. It judges a company's quality and its price separately, using criteria drawn from the financial literature (Warren Buffett, Michael Mauboussin, Aswath Damodaran).